Feedback / Questions
paclitaxel submicron particle (SOR007) - NanOlogy, DFB Pharma
https://www.businesswire.com/news/home/20220503005053/en/NanOlogy-Publishes-Results-from-a-Phase-12-Clinical-Trial-of-its-Topical-Investigational-Drug-in-the-Treatment-of-Cutaneous-Metastases-of-Breast-Cancer
May 3, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next